Tilman Seytter

Title: Innovations of Tilman Seytter

Introduction

Tilman Seytter is a notable inventor based in Graefelfing, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of hedgehog proteins. With a total of 3 patents, Seytter's work focuses on therapeutic applications that address critical health issues.

Latest Patents

One of Seytter's latest patents is for "Active Modified Hedgehog Proteins." This invention provides isolated highly active hedgehog proteins that are esterified with fatty acids containing 14 to 20 carbon atoms at the N-terminal domain. These proteins are particularly useful as therapeutic agents for treating bone disorders and neurodegenerative diseases. Additionally, methods for obtaining these highly active modified hedgehog proteins are also included in the patent. Another significant patent is for the "Active Hedgehog Protein Conjugate." This hedgehog conjugate is characterized by a polypeptide composed of 10 to 30 hydrophobic amino acids and/or amino acids that form transmembrane helices and are positively charged. It also includes aliphatic hydrocarbon residues with a chain length of 10 to 24 carbon atoms, which enhance its pharmaceutical activity.

Career Highlights

Tilman Seytter is currently associated with Curis, Inc., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential to revolutionize treatments for various medical conditions.

Collaborations

Seytter collaborates with notable colleagues, including Kurt Lang and Angelika Esswein. Their combined expertise contributes to the advancement of their research and development efforts.

Conclusion

Tilman Seytter's contributions to biotechnology through his innovative patents highlight his role as a significant inventor in the field. His work on hedgehog proteins has the potential to lead to groundbreaking therapeutic solutions.